| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | David J Stott | Q92190716 |
| Charles Boachie | Q117232907 | ||
| Stella Trompet | Q28516585 | ||
| Naveed Sattar | Q37378984 | ||
| Simon P. Mooijaart | Q41511676 | ||
| Paul Welsh | Q45405900 | ||
| J Wouter Jukema | Q64858750 | ||
| Patricia M Kearney | Q84978573 | ||
| Ian Ford | Q91610546 | ||
| P2093 | author name string | Emanuele Di Angelantonio | |
| Peter Willeit | |||
| Stefan Kiechl | |||
| Lena Tschiderer | |||
| Jonathan D W Evans | |||
| P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
| Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation | Q29615706 | ||
| Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial | Q29617817 | ||
| High-Sensitivity Troponin as a Biomarker in Heart Rhythm Disease | Q30235455 | ||
| Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis | Q31126960 | ||
| Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies | Q34469221 | ||
| Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study | Q34768805 | ||
| Comparison of three troponins as predictors of future cardiovascular events--prospective results from the FINRISK and BiomaCaRE studies | Q35110759 | ||
| Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study | Q35130613 | ||
| High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy | Q35648924 | ||
| Controlling the risk of spurious findings from meta-regression. | Q35782230 | ||
| Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers | Q35927436 | ||
| Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies: Does Utility Depend on Risk Thresholds For Treatment? | Q36472407 | ||
| Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality | Q36527607 | ||
| Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. | Q36574151 | ||
| Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study | Q36733964 | ||
| Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study | Q36851584 | ||
| Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium | Q37170644 | ||
| High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease | Q37524838 | ||
| Analytical characteristics of high-sensitivity cardiac troponin assays | Q37941605 | ||
| Prevalence of Positive Troponin and Echocardiogram Findings and Association With Mortality in Acute Ischemic Stroke | Q38851529 | ||
| High-Sensitivity Cardiac Troponin I Is a Strong Predictor of Cardiovascular Events and Mortality in the AGES-Reykjavik Community-Based Cohort of Older Individuals | Q38900727 | ||
| Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form | Q38947293 | ||
| High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort | Q39337183 | ||
| Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death | Q39579918 | ||
| High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis). | Q40350551 | ||
| High-sensitivity cardiac troponin I and incident coronary heart disease among asymptomatic older adults | Q40825589 | ||
| Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population | Q41666469 | ||
| Increased cardiac troponin I as measured by a high-sensitivity assay is associated with high odds of cardiovascular death: the Minnesota Heart Survey | Q42380662 | ||
| Early diagnosis of myocardial infarction with sensitive cardiac troponin assays | Q43285257 | ||
| High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men. | Q43719842 | ||
| Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population | Q44317661 | ||
| Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study | Q46209060 | ||
| Atrial fibrillation-induced cardiac troponin I release | Q46277769 | ||
| High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate | Q47444531 | ||
| Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure. | Q48121585 | ||
| Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention | Q48788707 | ||
| Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina | Q48913195 | ||
| Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. | Q50795240 | ||
| Gender, High-Sensitivity Troponin I, and the Risk of Cardiovascular Events (from the Nord-Trøndelag Health Study). | Q51619024 | ||
| Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. | Q53074660 | ||
| Circulating Cardiac Troponin T Exhibits a Diurnal Rhythm | Q57580327 | ||
| The design of a prospective study of pravastatin in the elderly at risk (PROSPER) | Q57653855 | ||
| On the relative value of an assay versus that of a test: a history of troponin for the diagnosis of myocardial infarction | Q84170310 | ||
| Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT study | Q86772177 | ||
| Cardiac troponin I levels in an elderly population from the community--The implications of sex | Q87196891 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| risk | Q104493 | ||
| risk assessment | Q1058438 | ||
| cytoskeletal proteins | Q66563066 | ||
| biomedical investigative technique | Q66648976 | ||
| contractile proteins | Q69633297 | ||
| macromolecular substance | Q75174158 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 558-568 | |
| P577 | publication date | 2017-08-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants | |
| P478 | volume | 70 |
| Q88409162 | A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High-Sensitivity Cardiac Troponin-I in Subjects With Stable Cardiovascular Disease |
| Q55279441 | Association between preoperative high sensitive troponin I levels and cardiovascular events after hip fracture surgery in the elderly. |
| Q94583868 | Associations of 24-Hour Urinary Sodium and Potassium Excretion with Cardiac Biomarkers: The Maastricht Study |
| Q90242232 | Cardiac Troponin T and Troponin I in the General Population |
| Q92920054 | Close association between circulating high-sensitivity cardiac troponin I and metabolic syndrome in the general population |
| Q64446871 | Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort |
| Q102379233 | Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19 |
| Q92598840 | Familial history of heart disease and increased risk for elevated troponin in apparently healthy individuals |
| Q47772072 | High sensitivity troponins in contemporary cardiology practice: are we turning a corner? |
| Q63682421 | High-Sensitivity Cardiac Troponin I Improves Cardiovascular Risk Prediction in Older Men: HIMS (The Health in Men Study) |
| Q57530015 | High-Sensitivity Troponin T and Incident Heart Failure in Older Men: British Regional Heart Study |
| Q57803980 | High-sensitive cardiac troponin T: a biomarker of left-ventricular diastolic dysfunction in hemodialysis patients |
| Q89721710 | Inpatient Mortality and 30-Day Readmission Rates Associated with Troponin Testing in Patients without Acute Myocardial Infarction |
| Q58545512 | Optimal Perioperative Blood Pressure Management |
| Q93148356 | Plasma-derived exosomal miR-183 associates with protein kinase activity and may serve as a novel predictive biomarker of myocardial ischemic injury |
| Q90041460 | Prognostic Value of a Novel and Established High-Sensitivity Troponin I Assay in Patients Presenting with Suspected Myocardial Infarction |
| Q92288947 | Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomes |
| Q92133268 | Revisiting the Biological Variability of Cardiac Troponin: Implications for Clinical Practice |
| Q61446690 | Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for cost efficiency? |
| Q92740639 | Stable atypical chest pain with negative anatomical or functional diagnostic test: Diagnosis no matter what or prevention at any cost? |
| Q55434159 | The trouble with troponin. |
| Q60044241 | Total serum cholinesterase activity predicts hemodynamic changes during exercise and associates with cardiac troponin detection in a sex-dependent manner |
| Q64097090 | True 99th centile of high sensitivity cardiac troponin for hospital patients: prospective, observational cohort study |
| Q61812257 | Two-peaked increase of serum myosin heavy chain-α after triathlon suggests heart muscle cell death |
Search more.